Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry

Asthma

Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma Registry

J Asthma Allergy

Le TT, Price DB, Erhard C, Cook B, Quinton A, Katial R, Christoff GC, Perez-de-Llano L, Altraja A, Bergeron C, Bourdin A, Koh MS, Lehtimäki L, Mahboub B, Papadopoulos NG, Pfeffer P, Rhee CK, Carter V, Martin N, Tran TN, EVEREST Study Working Group

doi: 10.2147/JAA.S468068

Asthma

Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR)

Allergy Asthma Immunol Res

Park SY, Lee D, Kim JH, Lee Y, Ban GY, Sim DW, Kwon JW, Kim SR, Song WJ, Park HW, Chang YS, Koh YI, Lee BJ, Park HS, Cho YS, Kim SH

doi: 10.4168/aair.2025.17.3.384

ERS 2024

Asthma

BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma

RECOMMENDED

Asthma

Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Boada-Fernández-Del-Campo C, García-Sánchez-Colomer M, Fernández-Quintana E, Poza-Guedes P, Rolingson-Landaeta JL, Sánchez-Machín I, González-Pérez R

doi: 10.3390/jcm13144192

Asthma

Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis

Respir Med

Zhu W, Chen K, Xiang Y, Shi J, Liang Y, Tong Y, Wang S, Zeng H, Zhang L, Ning X, Ye L, Jin M

doi: 10.1016/j.rmed.2025.108223

Respiratory Tract Infection

Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era

Clin Infect Dis

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Berry M, Amin AN, Sax PE, Kalil AC

doi: 10.1093/cid/ciae510

Pulmonary Hypertension

A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension

Respir Med

Paoli CJ, Zhang C, Tang X, Panjabi S, Thompson A, El-Kersh K

doi: 10.1016/j.rmed.2025.108112

RECOMMENDED

Asthma

Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial

★ 1 Recommended by Dr Martin Frey, Faculty Member

Allergy Asthma Immunol Res

Rhee CK, Park JW, Park HW, Noh H, Msihid J, Cho YS

doi: 10.4168/aair.2024.16.4.372

RECOMMENDED

AsthmaCOPD

Cardiovascular Events in Patients with Severe Asthma-A Retrospective Study of Two Cohorts: Asthma Type T2 Treated with Biologics and Non-Type T2

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Granda P, Villamañán E, Laorden D, Carpio C, Collada V, Domínguez-Ortega J, de Las Vecillas L, Romero-Ribate D, Chaparro-Díaz OF, Lázaro Miguel-Sin T, Alloca-Álvarez DJ, Correa-Borit JM, Losantos I, Mir-Ihara P, Narváez-Fernández EJ, Quirce S, Álvarez-Sala R

doi: 10.3390/jcm13154299

Related content

Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma Registry

Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR)

BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma

Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database

Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis

Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era

A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension

Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial

Cardiovascular Events in Patients with Severe Asthma-A Retrospective Study of Two Cohorts: Asthma Type T2 Treated with Biologics and Non-Type T2